Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials

Joanne M. Jeter, Tawnya L. Bowles, Clara Curiel-Lewandrowski, Susan M. Swetter, Fabian V. Filipp, Zalfa A. Abdel-Malek, Larisa J. Geskin, Jerry D. Brewer, Jack L. Arbiser, Jeffrey E. Gershenwald, Emily Y. Chu, John M. Kirkwood, Neil F. Box, Pauline Funchain, David E. Fisher, Kari L. Kendra, Ashfaq A. Marghoob, Suephy C. Chen, Michael E. Ming, Mark R. AlbertiniJohn T. Vetto, Kim A. Margolin, Sherry L. Pagoto, Jennifer L. Hay, Douglas Grossman, Darrel L. Ellis, Mohammed Kashani-Sabet, Aaron R. Mangold, Svetomir N. Markovic, Kelly C. Nelson, Jennifer G. Powers, June K. Robinson, Debjani Sahni, Aleksandar Sekulic, Vernon K. Sondak, Maria L. Wei, Jonathan S. Zager, Robert P. Dellavalle, John A. Thompson, Martin A. Weinstock, Sancy A. Leachman, Pamela B. Cassidy

Research output: Contribution to journal › Review article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences